Literature DB >> 6637329

Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.

K W Kastrup, J S Christiansen, J K Andersen, H Orskov.   

Abstract

The effect of more frequent (daily) injections of human growth hormone (hGH) on growth rate was studied in 16 growth hormone deficient children (12 boys, 4 girls) during 2 years. All had previously been treated with im injection of hGH 2-3 times weekly and in the majority of the patients a waning growth response was observed. For a total weekly dose of 12 IU hGH a daily dose of 2 IU was injected sc at night before sleep. This dosage has been shown by us to imitate the average nocturnal hGH profile in plasma. Growth response on the im treatment was 5.2 +/- 1.2 cm/year (SD) in boys and 5.4 +/- 0.9 cm/year in girls. A significant increase was seen during the first year of sc treatment to 7.9 +/- 2.7 cm in boys and 6.3 +/- 2 cm in girls. During the second year the growth response was still significantly increased in boys (7.2 +/- 1.9 cm). Bone age was more advanced and the period of previous im treatment was longer in girls (6.7 vs 3.6 years) which may be the main cause of the waning second year response (4.7 +/- 1.3 cm/year). Pubertal development occurred in 9 children during treatment. However, the highest growth rates were not found in these children. Absence of antibodies against hGH and local reactions at the injection site is evidence of the safety of the treatment, which was very well accepted by the children. Daily sc injections thus represent an effective alternative to conventional im injections ensuring high acceptance in children with growth hormone deficiency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6637329     DOI: 10.1530/acta.0.1040148

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  24 in total

1.  Long-term GH treatment of GH-deficient adults: comparison between one and two daily injections.

Authors:  C Höybye; M Rudling
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 2.  Optimization of growth hormone therapy in growth hormone deficient children.

Authors:  S M De Muinck Keizer-Schrama
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

3.  Long-acting growth hormone.

Authors:  Charlotte Höybye; Jens Sandahl Christiansen
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

4.  The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children.

Authors:  M Bozzola; G Radetti; S Pagani; M Draghi; G Aimaretti; G Rondini
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

5.  Evaluation of a pen injector system for growth hormone treatment.

Authors:  P D Gluckman; W S Cutfield
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

6.  Methionyl human growth hormone in Turner's syndrome.

Authors:  C Rongen-Westerlaken; J M Wit; S L Drop; B J Otten; W Oostdijk; H A Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 7.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

8.  Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.

Authors:  B Boersma; B Rikken; J M Wit
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

9.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

10.  The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.

Authors:  P A Baldwin; C K Klingbeil; C J Grimm; J P Longenecker
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.